SCLC, Extensive Stage Clinical Trials

38 clinical trials for SCLC, Extensive Stage across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer — RECRUITING · PHASE2
• Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients — RECRUITING · PHASE1
• 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer — RECRUITING · PHASE1
• Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC — RECRUITING · PHASE2
• Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC) — RECRUITING · PHASE1
• Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC — RECRUITING · PHASE2
• A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment — RECRUITING · PHASE1
• A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors — RECRUITING · PHASE2
• Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy — RECRUITING · PHASE2
• Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC — RECRUITING · PHASE1
• Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC) — RECRUITING · PHASE2
• Lung Cancer Registry — RECRUITING
• WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases — RECRUITING · PHASE1
• A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE3
• BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01) — NOT_YET_RECRUITING · PHASE3
• Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small Cell Lung Cancer Resistant to Second-line and Above Treatment — NOT_YET_RECRUITING · PHASE2
• A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC — ACTIVE_NOT_RECRUITING · PHASE2
• Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC — ACTIVE_NOT_RECRUITING · PHASE1
• Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer — COMPLETED · PHASE2
• Anlotinib in Cross-line Treatment of NSCLC and SCLC — NOT_YET_RECRUITING
• Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer — NOT_YET_RECRUITING
• A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy Progression — NOT_YET_RECRUITING · PHASE2
• Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide — COMPLETED · PHASE2
• An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing — NOT_YET_RECRUITING · PHASE1
• A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer — COMPLETED · PHASE1
• Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia — NOT_YET_RECRUITING · PHASE2
• Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance — COMPLETED
• A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE2
• Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC — COMPLETED · PHASE1
• A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer — OTHER
• TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors — OTHER · PHASE2
• Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer — OTHER · PHASE1
• Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer — OTHER · PHASE2
• Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer — OTHER · NA

Refine this search